http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4501912-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46443201668cc985a4ce2fb287770f99 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 |
| filingDate | 1982-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1985-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59cc3ede3f82fb39715ae26927439440 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_804c82c57404e066f32032e455808105 |
| publicationDate | 1985-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4501912-A |
| titleOfInvention | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents |
| abstract | A method for the treatment of glaucoma or lowering intraocular pressure in a mammal, involving topically administering to the eye of such mammal a selectively metabolized beta-blocking compound of the formula <IMAGE> wherein R may be lower alkyl, lower hydroxyalkyl, lower alkynyl, aralkyl, or an ester-containing group and Ar may be substituted or unsubstituted aromatic; or a pharmaceutically acceptable salt thereof. Because of a relatively long duration of action of such compounds in ocular fluids and a relatively short duration of action in the systemic circulation, such compounds are useful for the treatment of excessive intraocular pressure without substantial systemic effects. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5536749-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5543083-A |
| priorityDate | 1981-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.